Nan Su

9.6k citations

121 papers · 6.9k · 3 hit papers · h-index 34

Impact in

Cancer Research top 2%
Molecular Biology top 2%
- Fibroblast Growth Factor Research
- Epigenetics and DNA Methylation
- Single-cell and spatial transcriptomics
- RNA Research and Splicing
- RNA modifications and cancer

Papers in

Molecular Biology 51
- Fibroblast Growth Factor Research 17
- Molecular Biology Techniques and Applications 6
- RNA Research and Splicing 5
- RNA modifications and cancer 5
Genetics 19
- Connective tissue disorders research 10
- Insect and Arachnid Ecology and Behavior 5

Co-authors: Yuling Luo (9 shared papers)Xingyong Wu (7 shared papers)Son Bui (6 shared papers)Xiao-Jun Ma (2 shared papers)Fay Wang (1 shared paper)John J. Flanagan (1 shared paper)Michael S. Kilberg (3 shared papers)Jixiu Shan (1 shared paper)
Journals: International Journal of Biological Sciences (5 papers)Human Molecular Genetics (3 papers)Cardiovascular Drugs and Therapy (2 papers)Frontiers in Oncology (2 papers)Scientific Reports (2 papers)
Partner nations: China United States Australia

In The Last Decade

Nan Su

111 papers receiving 6.8k citations

Nan Su's Hit Papers

align trajectories log scale

FGF/FGFR signaling in health and disease 2020 · 594 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Signal Transduction and Targeted Therapy
2011 Journal of Molecular Diagnostics
2011 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Nan Su

Since Specialization

Citations

This map shows the geographic impact of Nan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Su more than expected).

Fields of papers citing papers by Nan Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Su. The network helps show where Nan Su may publish in the future.

Co-authors

The 25 scholars most cited alongside Nan Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nan Su Line = papers co-authored together Nan Su links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	RNAscope Journal of Molecular Diagnostics ·Fay Wang, John J. Flanagan, Nan Su, Li-Chong Wang, Son Bui, Allissa Nielson, Xingyong Wu, Hong-Thuy Vo, Xiao-Jun Ma, Yuling Luo Hit paper breakdown →	2011	1912
2	The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations Proceedings of the National Academy of Sciences ·Kelley S. Yan, Luis A. Chia, Xingnan Li, Akifumi Ootani, James Su, Josephine Y. Lee, Nan Su, Yuling Luo, Sarah C. Heilshorn, Manuel R. Amieva, Eugenio Sangiorgi, Mario R. Capecchi, Calvin J. Kuo Hit paper breakdown →	2011	662
3	FGF/FGFR signaling in health and disease Signal Transduction and Targeted Therapy ·Yangli Xie, Nan Su, Jing Yang, Qiaoyan Tan, Shuo Huang, Min Jin, Zhenhong Ni, Bin Zhang, Dali Zhang, Fengtao Luo, Hangang Chen, Xianding Sun, Jian Q. Feng, Huabing Qi, Lin Chen Hit paper breakdown →	2020	594
4	ATF4-dependent transcription mediates signaling of amino acid limitation Trends in Endocrinology and Metabolism ·Michael S. Kilberg, Jixiu Shan, Nan Su	2009	496
5	Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models Bone Research ·Nan Su, Min Jin, Lin Chen	2014	236
6	Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial The Lancet ·Jiangtao Lin, Jiansan Zhang, Xiao‐Ping Dong, (unknown), Jiangting Chen, Nan Su, Qiang Gao, Zhenshan Zhang, Yuxuan Liu, Zhihong Wang, Meng Yang, Ruihua Sun, Changgui Li, Su Ching Lin, Mei Ji, Yan Liu, Xu Wang, John Wood, Zijian Feng, Yu Wang, Weidong Yin	2006	228
7	C/EBP Homology Protein (CHOP) Interacts with Activating Transcription Factor 4 (ATF4) and Negatively Regulates the Stress-dependent Induction of the Asparagine Synthetase Gene Journal of Biological Chemistry ·Nan Su, Michael S. Kilberg	2008	146
8	The exosome-like vesicles from osteoarthritic chondrocyte enhanced mature IL-1β production of macrophages and aggravated synovitis in osteoarthritis Cell Death and Disease ·Zhenhong Ni, Liang Kuang, Hangang Chen, Yangli Xie, Bin Zhang, Junjie Ouyang, Jiangyi Wu, Siru Zhou, Liang Chen, Nan Su, Qiaoyan Tan, Xiaoqing Luo, Bo Chen, Daiwen Chen, Liangjun Yin, Haiyang Huang, Xiaolan Du, Lin Chen	2019	146
9	Specific Regulation of NRG1 Isoform Expression by Neuronal Activity Journal of Neuroscience ·Xihui Liu, Ryan Bates, Dong‐Min Yin, Chong Shen, Fang Wang, Nan Su, Sergei A. Kirov, Yanwei Luo, J.-Z. Wang, Wen‐Cheng Xiong, Lin Mei	2011	142
10	A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis Bone ·Liangjun Yin, Xiaolan Du, Cuiling Li, Xiaoling Xu, Zhi Chen, Nan Su, Ling Zhao, Huabing Qi, Fubing Li, Jing Xue, Jing Yang, Min Jin, (unknown), Lin Chen	2007	121
11	Astrocyte activation is suppressed in both normal and injured brain by FGF signaling Proceedings of the National Academy of Sciences ·Wenfei Kang, Francesca Balordi, Nan Su, Lin Chen, Gord Fishell, Jean M. Hébert	2014	120
12	Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer Oncogene ·Sheng Zhong, C. Robert Fields, Nan Su, (unknown), Keith D. Robertson	2006	104
13	An F‐box gene, CPR30, functions as a negative regulator of the defense response in Arabidopsis The Plant Journal ·Mingyue Gou, Nan Su, Jun Zheng, Junling Huai, Guangheng Wu, Jinfeng Zhao, Junguang He, Dingzhong Tang, Shuhua Yang, Guoying Wang	2009	98
14	SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B/IL-1β and contributes to LIPUS-mediated anti-inflammatory effect Autophagy ·Bin Zhang, Hangang Chen, Junjie Ouyang, Yangli Xie, Liang Chen, Qiaoyan Tan, Xiaolan Du, Nan Su, Zhenhong Ni, Lin Chen	2019	98
15	Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis Human Molecular Genetics ·Nan Su, Qingfang Sun, Chao Li, Xiaojie Lu, Huabing Qi, Songmeng Chen, (unknown), X. Du, Lei Zhao, Qing He, Min‐Sun Jin, Ya Shen, D. Chen, L. Chen	2010	87
16	Bone function, dysfunction and its role in diseases including critical illness International Journal of Biological Sciences ·Nan Su, Jing Yang, Yangli Xie, Xiaolan Du, Hangang Chen, (unknown), Lin Chen	2019	87
17	Fully Automated RNAscope In Situ Hybridization Assays for Formalin‐Fixed Paraffin‐Embedded Cells and Tissues Journal of Cellular Biochemistry ·Courtney Anderson, Bingqing Zhang, Melanie Miller, Emerald Butko, Xingyong Wu, Thomas W. Laver, Casey Kernag, Jeffrey Kim, Yuling Luo, Henry Lamparski, Emily Park, Nan Su, Xiaojun Ma	2016	80
18	Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines Pediatric Blood & Cancer ·Nan Su, Yuan‐Xiang Pan, Mi Zhou, Richard C. Harvey, Stephen P. Hunger, Michael S. Kilberg	2007	77
19	Role of Wnt/β-catenin pathway in inducing autophagy and apoptosis in multiple myeloma cells Oncology Letters ·Nan Su, Pingping Wang, Yan Li	2016	63
20	Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma Journal of Molecular Diagnostics ·Zhen Wang, Bryce P. Portier, Aaron M. Gruver, Son Bui, Hongwei Wang, Nan Su, Hong-Thuy Vo, Xiao-Jun Ma, Yuling Luo, G. Thomas Budd, Raymond R. Tubbs	2013	61

About Nan Su

Nan Su is a scholar working on Molecular Biology, Genetics, Oncology, Epidemiology and Cancer Research, having authored 121 papers that have together received 6.9k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (17 papers), Connective tissue disorders research (10 papers), Molecular Biology Techniques and Applications (6 papers), Insect and Arachnid Ecology and Behavior (5 papers), RNA Research and Splicing (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Cancer Research (720 citations), Molecular Biology (3.5k citations), Oncology (979 citations), Genetics (1.0k citations) and Cell Biology (586 citations). Nan Su has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yuling Luo, Xingyong Wu, Son Bui, Xiao-Jun Ma, Fay Wang, John J. Flanagan, Michael S. Kilberg, Jixiu Shan, Min Jin and Lin Chen. Their work appears in journals such as International Journal of Biological Sciences, Human Molecular Genetics, Cardiovascular Drugs and Therapy, Frontiers in Oncology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Nan Su

Impact in

Papers in i

In The Last Decade

Nan Su

Nan Su's Hit Papers

Peers

Countries citing papers authored by Nan Su

Fields of papers citing papers by Nan Su

All Works

About Nan Su

Explore authors with similar magnitude of impact

Papers in